Xenon Pharmaceuticals Inc. (XENE) Form 10-K Annual Reports
Xenon Pharmaceuticals Inc. (XENE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XENE
CIK: 1582313
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerHolly Reeves
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | 4 | 0001193125-26-424428 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 | 0001193125-26-410001 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 | 0001193125-26-409999 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 | 0001193125-26-382412 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-28 | 4 | 0001193125-26-377309 | View SEC Doc Filr Page |
| 144 | 2026-08-28 | — | 144 Filing | 0001950047-26-008816 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 | 0001193125-26-349351 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001193125-26-349336 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000902219-26-000248 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002245 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338244 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338019 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002171 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | 4 | 0001193125-26-262672 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | 4 | 0001193125-26-262671 | View SEC Doc Filr Page |
| 144 | 2026-06-05 | — | 144 Filing | 0001950047-26-005712 | View SEC Doc Filr Page |
| 144 | 2026-06-05 | — | 144 Filing | 0001950047-26-005710 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256126 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256125 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256124 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256122 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256121 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256120 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256118 | View SEC Doc Filr Page |
| S-8 POS | 2026-06-03 | — | S-8 POS | 0001193125-26-255544 | View SEC Doc Filr Page |